GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » athenahealth Inc (NAS:ATHN) » Definitions » 3-Year RORE %

athenahealth (athenahealth) 3-Year RORE % : 0.00% (As of Sep. 2018)


View and export this data going back to 2007. Start your Free Trial

What is athenahealth 3-Year RORE %?

Return on Retained Earnings (RORE) is an indicator of a company's growth potential, it shows how much a company earns by reinvesting its retained earnings, i.e. profits after dividend payments. athenahealth's 3-Year RORE % for the quarter that ended in Sep. 2018 was 0.00%.

The industry rank for athenahealth's 3-Year RORE % or its related term are showing as below:

ATHN's 3-Year RORE % is not ranked *
in the Healthcare Providers & Services industry.
Industry Median: 1.105
* Ranked among companies with meaningful 3-Year RORE % only.

athenahealth 3-Year RORE % Historical Data

The historical data trend for athenahealth's 3-Year RORE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

athenahealth 3-Year RORE % Chart

athenahealth Annual Data
Trend Dec08 Dec09 Dec10 Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17
3-Year RORE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

athenahealth Quarterly Data
Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18
3-Year RORE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of athenahealth's 3-Year RORE %

For the Health Information Services subindustry, athenahealth's 3-Year RORE %, along with its competitors' market caps and 3-Year RORE % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


athenahealth's 3-Year RORE % Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, athenahealth's 3-Year RORE % distribution charts can be found below:

* The bar in red indicates where athenahealth's 3-Year RORE % falls into.



athenahealth 3-Year RORE % Calculation

athenahealth's 3-Year RORE % for the quarter that ended in Sep. 2018 is calculated as:

3-Year RORE %=( Most Recent EPS (Diluted)- First Period EPS (Diluted) )/( Cumulative EPS (Diluted) for 3-year -Cumulative Dividends per Share for 3-year )
=( 3.07-0.47 )/( 4.31-0 )
=2.6/4.31
=60.32 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of 3-Year RORE %, the most recent and first period EPS (Diluted) is the trailing twelve months (TTM) data ended in Sep. 2018 and 3-year before.


athenahealth  (NAS:ATHN) 3-Year RORE % Explanation

Return on Retained Earnings (RORE) is important to investors because it reveals a company's efficiency and growth potential. A higher RORE indicates a higher return. A high RORE indicates that the company should reinvest profits into the business. A lower RORE suggests that the company should distribute profits to shareholders by paying out dividends, since those dollars aren't generating much additional growth for the company.

There are a several different ways to arrive at the Return on Retained Earnings. The simplest way to calculate it is by using published information on Earnings per Share (EPS) and Dividend per Share (DPS) over a selected period. Here, 3-year period is chosen.

Be Aware

Please keep in mind that the RORE is relative to the nature of the business and its competitors. If another company in the same sector is producing a lower return on retained earnings, it doesn’t necessarily mean it’s a bad investment. It may just suggest the company is older and no longer in a high growth stage. At such a stage in the business cycle, it would be expected to see a lower RORE and higher dividend payout.


athenahealth 3-Year RORE % Related Terms

Thank you for viewing the detailed overview of athenahealth's 3-Year RORE % provided by GuruFocus.com. Please click on the following links to see related term pages.


athenahealth (athenahealth) Business Description

Traded in Other Exchanges
N/A
Address
Athenahealth provides healthcare IT (HCIT) services through cloud-based and mobile application products largely for smaller to midsize medical groups and health systems. Their services include revenue cycle and practice management, electronic health records, patient engagement, population health management, and care coordination. The business services segment generates 96% of revenue, which provides cloud-based solutions and support to healthcare providers. Athenahealth is headquartered in Waltham, Massachusetts.
Executives
Brian P Mckeon director IDEXX LABORATORIES, ONE IDEXX DRIVE, WESTBROOK ME 04092
John A Kane director C/O MERCHANTS BANCSHARES, INC., 275 KENNEDY DRIVE, SOUTH BURLINGTON VT 05403
Dev Ittycheria director C/O MONGO DB, INC., 1633 BROADWAY, 38TH FLOOR, NEW YORK NY 10019
Ed Park director 311 ARSENAL STREET WATERTOWN MA 02472
Brandon H Hull director 221 NASSAU STREET, PRINCETON NJ 08542
Thomas J Szkutak director P O BOX 81226, SEATTLE WA 98108-1226
Jeffrey R Immelt director, other: Executive Chairman GENERAL ELECTRIC COMPANY, 41 FARNSWORTH STREET, BOSTON MA 02210
Marc A Levine officer: Chief Financial Officer C/O ATHENAHEALTH, INC., 311 ARSENAL STREET, WATERTOWN MA 02472
Jacqueline B Kosecoff director 5960 HEISLEY ROAD, MENTOR OH 44060
Amy Abernethy director 311 ARSENAL STREET, WATERTOWN MA 02472
Kristi Ann Matus officer: EVP and CFAO C/O EQUITABLE HOLDINGS, INC., 1290 AVENUE OF THE AMERICAS, NEW YORK NY 10104
Daniel H. Orenstein officer: SVP, GC, and Secretary 311 ARSENAL STREET, WATERTOWN MA 02472
Jeremy Delinsky officer: SVP, Chief Product Officer C/O WAYFAIR INC., 4 COPLEY PLACE, 7TH FLOOR, BOSTON MA 02116
Timothy M Adams officer: CFO & SVP 311 ARSENAL STREET, WATERTOWN MA 02472
Bryan E Roberts director C/O VENROCK ASSOCIATES, 2494 SAND HILL ROAD STE 200, MENLO PARK CA 94025

athenahealth (athenahealth) Headlines

From GuruFocus